As of 2025-10-29, the Relative Valuation of Sangamo Therapeutics Inc (SGMO) is (4.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.59 USD, the upside of Sangamo Therapeutics Inc based on Relative Valuation is -868.4%.
The range of the Relative Valuation is (3.92) - (4.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 22.2x | 19.7x |
| Forward P/E multiples | 18.7x - 28.4x | 23.6x |
| Fair Price | (3.92) - (4.65) | (4.54) |
| Upside | -763.1% - -887.4% | -868.4% |
| Date | P/E |
| 2025-10-27 | -3.00 |
| 2025-10-24 | -3.02 |
| 2025-10-23 | -3.13 |
| 2025-10-22 | -3.15 |
| 2025-10-21 | -3.07 |
| 2025-10-20 | -3.22 |
| 2025-10-17 | -3.05 |
| 2025-10-16 | -3.07 |
| 2025-10-15 | -3.29 |
| 2025-10-14 | -3.27 |
| 2025-10-13 | -3.22 |
| 2025-10-10 | -3.20 |
| 2025-10-09 | -3.52 |
| 2025-10-08 | -3.30 |
| 2025-10-07 | -3.33 |
| 2025-10-06 | -3.33 |
| 2025-10-03 | -3.25 |
| 2025-10-02 | -3.34 |
| 2025-10-01 | -3.22 |
| 2025-09-30 | -3.21 |
| 2025-09-29 | -3.34 |
| 2025-09-26 | -3.16 |
| 2025-09-25 | -3.02 |
| 2025-09-24 | -2.69 |
| 2025-09-23 | -2.51 |
| 2025-09-22 | -2.63 |
| 2025-09-19 | -2.60 |
| 2025-09-18 | -2.62 |
| 2025-09-17 | -2.44 |
| 2025-09-16 | -2.45 |
| 2025-09-15 | -2.38 |
| 2025-09-12 | -2.41 |
| 2025-09-11 | -2.53 |
| 2025-09-10 | -2.53 |
| 2025-09-09 | -2.48 |
| 2025-09-08 | -2.50 |
| 2025-09-05 | -2.61 |
| 2025-09-04 | -2.53 |
| 2025-09-03 | -2.54 |
| 2025-09-02 | -2.57 |
| 2025-08-29 | -2.48 |
| 2025-08-28 | -2.58 |
| 2025-08-27 | -2.57 |
| 2025-08-26 | -2.57 |
| 2025-08-25 | -2.62 |
| 2025-08-22 | -2.79 |
| 2025-08-21 | -2.73 |
| 2025-08-20 | -2.57 |
| 2025-08-19 | -2.67 |
| 2025-08-18 | -2.81 |